Peter Boockvar, CIO of Bleakley Advisory Group, joins Real Vision editor Jack Farley to break down his market outlook as stimulus talks draw to a close and an alarming new strain of COVID-19 spreads throughout the United Kingdom. Boockvar makes his case for why inflation will continue to rise alongside nominal yields in 2021, and he explains why this macro outlook leads him to look favorably upon commodities and value stocks that trade at significantly low price/earnings multiples since he expects multiples to compress across the equity landscape as nominal yields rise. Boockvar gives a strategic update on the state of the Fed's QE programs and argues that the expiration of the Fed's emergency lending programs is not unwelcome and, in fact, is overdue. Lastly, Boockvar shares with Farley several stocks on his radar, such as CVS Health Corp ($CVS) and Walgreens Boots Alliance Inc ($WBA) as well as evaluates their future business prospect. In the intro, Real Vision’s Haley Draznin monitors the markets as stimulus relief package passes in the US and a new strain of the coronavirus emerged in England, prompting fresh travel restrictions across Europe. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related